CAS 879127-07-8

EGFR Inhibitor

CAS: 879127-07-8

Fórmula: C₂₁H₁₈F₃N₅O

Pureza: 95%

Forma y color: Solid

Peso molecular: 413.3957

Ref: IN-DA008CAI

EGFR-IN-12

CAS: 879127-07-8

EGFR-IN-12

Pureza: ≥98%

Peso molecular: 413.4g/mol

Ref: 54-BUP12535

N-(3-((6-((3-(Trifluoromethyl)Phenyl)Amino)Pyrimidin-4-Yl)Amino)Phenyl)Cyclopropanecarboxamide

CAS: 879127-07-8

N-(3-((6-((3-(Trifluoromethyl)Phenyl)Amino)Pyrimidin-4-Yl)Amino)Phenyl)Cyclopropanecarboxamide

Pureza: 98%

Peso molecular: 413.4g/mol

Ref: 54-PC108706

EGFR-IN-12

CAS: 879127-07-8

EGFR-IN-12 (EGFR Inhibitor) is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.

Fórmula: C₂₁H₁₈F₃N₅O

Pureza: 98.3% - 99.76%

Forma y color: Solid

Peso molecular: 413.4

Ref: TM-T5168

EGFR Inhibitor

CAS: 879127-07-8

EGFR Inhibitor is a drug that inhibits the epidermal growth factor receptor (EGFR) and prevents the activation of the EGFR. This drug is used to treat cancer, such as lung cancer and pancreatic cancer. EGFR inhibitors are drugs that inhibit the epidermal growth factor receptor (EGFR). EGFR inhibitors can be classified into two groups: tyrosine kinase inhibitors and monoclonal antibodies. The most common EGFR inhibitor is erlotinib (Tarceva), which is used for treating lung cancer, pancreatic cancer, head and neck cancers, and other types of cancers. Gefitinib (Iressa) is another type of EGFR inhibitor that has been shown to be effective against colorectal cancer.

Fórmula: C₂₁H₁₈F₃N₅O

Pureza: Min. 95%

Peso molecular: 413.4 g/mol

Ref: 3D-EKB12707